Micell Technologies Inc. announced commercialization plans for its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES). In support of this strategy, the company has entered into a five-year agreement with Stentys as an exclusive worldwide distributor of the MiStent SES, except in the United States, Canada, China, South Korea and Japan. Stentys plans to launch MiStent in the first half of 2015 in Europe, followed by many other geographies where they have built a commercial network

KLAS releases scores and analysis regarding solutions for electronic medical record (EMR) interoperability and health information exchanges (HIEs). This, to provide clarity into a market that is cluttered with competing claims.

Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations, Medtronic Inc. announces CE mark and international launch of the Resolute Onyx Drug-Eluting Stent (DES). The first live patient implant of the Resolute Onyx DES occurred recently during the XII International Course of Endovascular and Myocardial Therapy in Madrid, Spain. The Resolute Onyx Drug-Eluting Stent is not approved in the United States.

The actions — or inaction — of patients should be considered in programs designed to improve care and patient outcomes, according to a report released by the American College of Cardiology, American Heart Association, American Association of Cardiovascular and Pulmonary Rehabilitation, American Academy of Family Physicians and the American Nurses Association in collaboration with other professional organizations.

Catalist-listed QT Vascular Ltd. has acquired a novel technology platform called Java, and all associated intellectual property, which was developed independently in Israel.

TIDI Products LLC has acquired CFI Medical Solutions (CFI) of Fenton, Mich., a diversified medical device manufacturer and engineering resource for hospitals, distributors and global original equipment manufacturers.

Medic Vision Imaging Solutions Ltd. will showcase its SafeCT Enterprise solution at the upcoming Radiological Society of North America's (RSNA's) 100th Scientific Assembly and Annual Meeting, Nov. 30 - Dec. 5 in Chicago. SafeCT is a turnkey solution pioneered to revitalize existing computed tomography (CT) scanners with CT image enhancement for low-dose scans to enable low-dose imaging with high-quality image results for diagnosis. This provides hospitals and imaging centers with a cost-effective option in place of a costly scanner retrofit or replacement.